Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | APP | P05067 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | TTR | P02766 | 3/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | CA6 | P23280 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22442012 | 0.84 | PTGS1 (0.64) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL21643902 | 0.81 | PTPN1 (1.00) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL28226138 | 0.81 | PTPN1 (1.00) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL30983773 | 0.81 | PTPN1 (1.00) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL14966981 | 0.81 | PTPN1 (1.00) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL31414592 | 0.78 | PTPN1 (0.68) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL28525386 | 0.78 | PTPN1 (0.68) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL31414593 | 0.78 | PTPN1 (0.68) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL29126777 | 0.78 | PTPN1 (0.68) | PTPN1MAPTAPPMEN1CYP3A4 | |
| SCHEMBL13313586 | 0.78 | PTPN1 (0.68) | PTPN1MAPTAPPMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024238399-A1 | METHODS OF MANUFACTURING ADENO-ASSOCIATED VIRAL VECTORS | SIREN BIOTECHNOLOGY, INC. (US) | 2024-11-21 | — | — | WO | claimed |
| EP-4427758-A1 | NEW SYNERGISTIC ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIBACTERIAL ASSOCIATION | NOOS S.r.l. (IT) | 2024-09-11 | — | — | EP | claimed |
| US-20230141224-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | FIGENE, LLC | 2023-05-11 | — | — | US | claimed |
| EP-4142751-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | Figene, LLC (US) | 2023-03-08 | — | — | EP | claimed |
| WO-2021202032-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | FIGENE, LLC (US) | 2021-10-07 | — | — | WO | claimed |
| WO-2024238399-A1 | METHODS OF MANUFACTURING ADENO-ASSOCIATED VIRAL VECTORS | SIREN BIOTECHNOLOGY, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| EP-4427758-A1 | NEW SYNERGISTIC ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIBACTERIAL ASSOCIATION | NOOS S.r.l. (IT) | 2024-09-11 | — | — | EP | disclosed |
| US-20230141224-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | FIGENE, LLC | 2023-05-11 | — | — | US | disclosed |
| US-20230127499-A1 | PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS | FIGENE, LLC | 2023-04-27 | — | — | US | disclosed |
| EP-4142751-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | Figene, LLC (US) | 2023-03-08 | — | — | EP | disclosed |
| WO-2021202032-A1 | FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | FIGENE, LLC (US) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021202031-A1 | PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS | FIGENE, LLC (US) | 2021-10-07 | — | — | WO | disclosed |